PBEvsEKGETF Comparison
VS
ETF 2
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
This fund is part of
Healthcare Technology
+0.38%
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is part of the Healthcare Technology segment. Both ETFs have the same top 1 sector exposures: Healthcare. PBE is less expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.65% for EKG. PBE is up 14.59% year-to-date (YTD) with +$114M in YTD flows. EKG performs worse with 11.43% YTD performance, and +$963K in YTD flows. Run a side-by-side ETF comparison of PBE and EKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBE vs EKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE EKG | -0.70%+0.39% | +12.83%+21.17% | +14.59%+11.43% | +35.63%+22.85% | +57.51%+36.04% | +23.66%n/a |
| Flows | PBE EKG | +$44M- | +$117M+$963K | +$114M+$963K | +$113M+$963K | +$62M+$2M | +$64M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE EKG | +19.58%+26.19% | +19.33%+23.51% | +20.48%+23.84% | +22.57%n/a |
| Max drawdown | PBE EKG | -5.73%-7.45% | -11.70%-22.11% | -22.21%-24.32% | -33.32%n/a |
| Max drawdown duration | PBE EKG | 7d28d | 166d208d | 324d264d | 1509dn/a |
Trading data
PBE | EKG | |
Last sale 9/11/2026 at 1:30 PM | $92.91 | $21.35 |
| Previous close 09/10/2026 | $93.03 | $21.17 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBE | EKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
PBE | EKG | |
|---|---|---|
| Last price | $92.91 | $21.35 |
| 1D performance | -0.13% | +0.83% |
| AuM | $405.87 M | $4.23 M |
| E/R | 0.59% | 0.65% |
Characteristics
PBE | EKG | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | First Trust |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | Nasdaq Lux Health Tech Index |
| N° of holdings | 30 | 37 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | March 22, 2022 |
| ESG | No | No |
Advertisement
Exposure
Countries
PBE
USA
97.13%
Other
2.87%
EKG
USA
95.72%
Other
4.28%
Sectors
PBE
Healthcare
100%
Other
0%
EKG
Healthcare
98.67%
Other
1.33%
Advertisement
Diversification
PBE
Total weight of top 15 holdings out of 15
61.32%
EKG
Total weight of top 15 holdings out of 15
74.55%
Top 15 holdings
Data as of July 31, 2026
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
EKG
IQVIA Holdings, Inc.
9.37%
Veeva Systems, Inc.
9.01%
DexCom, Inc.
8.04%
Guardant Health, Inc.
5.85%
ResMed, Inc.
5.83%
Illumina, Inc.
5.19%
Natera, Inc.
5.11%
Intuitive Surgical, Inc.
4.87%
Oscar Health, Inc.
3.90%
Tempus AI, Inc.
3.64%
QIAGEN NV
2.95%
Globus Medical, Inc.
2.94%
Align Technology, Inc.
2.74%
10X Genomics, Inc.
2.57%
Hims & Hers Health, Inc.
2.54%
Frequently asked questions about PBE and EKG
How have the PBE and EKG ETFs performed in 2026?
As of September 10, 2026, PBE is up 14.59% year-to-date (YTD), while EKG has returned 11.43%. That puts PBE better performer ahead so far this year.
Which ETF is attracting more investor money: PBE or EKG?
Year-to-date, the PBE ETF saw +$114M in flows, compared to +$963K for EKG.
Which ETF is more volatile: PBE or EKG?
Over the past year, PBE had a volatility of 19.33%, while EKG experienced 23.51%.
Which ETF is bigger: PBE or EKG?
As of September 10, 2026, PBE holds $405.87 M in assets under management (AUM), while EKG manages $4.23 M.
What sectors do the PBE and EKG ETFs invest in?
PBE leans toward sectors like Healthcare. Meanwhile, EKG focuses on Healthcare.
What are the top holdings of the PBE ETF and EKG ETF?
PBE top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. EKG holds in its top three: IQVIA Holdings, Inc., Veeva Systems, Inc. and DexCom, Inc..
Which ETF is more diversified: PBE or EKG?
PBE holds 30 securities with 61.32% of its assets in the top 15. EKG has 37 securities and a top 15 weight of 74.55%.
Advertisement
Advertisement
